The lentiviral vector used to co-express 2-E+2-3a was LV-E3a (Vectorbuilder ID VB210112-1153ufz) and its respective control vector LV-EV (Vectorbuilder ID VB210112-1153ufz). The LV-E3a vector contains the cytomegalovirus (CMV) promoter, the 2-E+2-3a viroporins obtained from Gordon et al., 2020 (18 (link)) separated by a 2A peptide site, and terminated by a SV40 late polyA sequence cloned into the LV-EV vector. The viroporin sequences deduced from the protein sequences were modified by adding an ATG codon 5’ and three N-terminal FLAG-tags added to the 3’ end of each viral protein. LV-EV is an empty vector.
The lentiviral vector expressing our mCAT and its respective control vector were LV-mCAT (VectorBuilder 210909-1242kdf) and LV-EV (VectorBuilder 900122-0484ubz). The LV-mCAT vector includes the EFS promoter, EGFP, 2A peptide site, mCAT, and SV40 late polyA sequence. The LV-EVcontrol vector lacks the EGFP and mCAT sequences.
Free full text: Click here